Font Size:
a
A
A
Keyword [ICIs]
Result: 1 - 20 | Page: 1 of 2
1.
Prognostic And Predictive Roles Of TMB And CNA Across Metastatic Pan-cancer:immunotherapeutic Implications
2.
A study of the reliability and concurrent validity of the ICIS-Urban teacher interview instrument
3.
Effectiveness And Safety Of ICIs Combined With Anti-angiogenic Drugs Versus Double Medicine Combined With Chemotherapy For Patients With Advanced Her-2-negative Gastric Or Gastroesophageal Junction Cancer
4.
The Effect Of Smoking History On The Efficacy Of Immune Checkpoint Inhibitors In Advanced Non-Small Cell Lung Cancer:a Meta-Analysis
5.
Based On Literature And Real World Studies,the Study On The Clinical Efficacy Of The Traditional Chinese Medicine For Yiqi Qutan Prescription Combined With PD1/PD-L1 Monoclonal Antibody In The Treatment Of Advanced Lung Cancer
6.
Meta-analysis Of Related Adverse Events Caused By ICIs Alone Or Combined With Routine Chemotherapy In The Treatment Of NSCLC
7.
Correlation Between Immune-Related Adverse Events Of Immune Checkpoint Inhibitors And The Efficacy
8.
Investigation On Predictors In The Outcome Of Immune Checkpoint Inhibitors(ICIs) And Hyperprogressive Disease Triggered By ICIs
9.
Investigation And Mechanism Exploration On The Association Of PRKDC Mutation And Response To Immune Checkpoint Inhibitors In Advanced Solid Tumors
10.
CCND1 Amplification Contributes To Immunosuppression And The Correlation With Clinical Efficacy Of Immune Checkpoint Inhibitors In Solid Tumors
11.
Relationship Between KRAS Gene Status And Immunotherapy Efficacy And Prognosisin Patients With Advanced NSCLC
12.
Development Of Unconventional Response And Related Efficacy Evaluation Of ICIs In The Treatment Of Solid Tumors
13.
The Role Of PNI In Predicting The Efficacy And Prognosis Of ICIs In Patients With Advanced NSCLC
14.
Apatinib Combined With ICIs As A Preliminary Study On The Clinical Efficacy And Safety Of Third-line Treatment For Metastatic Gastric Cancer
15.
The Expression Of Tumor Mutation Board And Programmed Cell Death Ligand 1 In Esophageal Squamous Cell Carcinoma And Its Clinical Significance
16.
Efficacy And Safety Of ICIs In Lung Cancer Patients With Concomitant COPD: A Meta-analysis Of Observational Studies
17.
Predictive Biomarkers For Immune Checkpoint Inhibitors-based Treatment In Advanced Lung Cancer Patients
18.
The Predictive Value And Clinical Application Of Peripheral Blood Biomarkers In Immunotherapy Of Advanced Non-small Cell Lung Cancer
19.
Effect Of SBRT For Different Organ Lesions On Peripheral Blood Immunophenotype And ICIs Therapy In Advanced NSCLC And Its Mechanism
20.
Single-cell Sequencing Reveals Neoadjuvant Immune Landscape In Non-small Cell Lung Cancer
<<First
<Prev
Next>
Last>>
Jump to